传奇生物裁撤中国销售团队?!CAR-T产品深陷商业化困境...

谈思生物
Jun 14

2025.06.14本文字数:1120,阅读时长大约2.8分钟导读:传奇生物裁撤中国销售团队,背后是国内CAR-T疗法商业化困境。其明星产品西达基奥仑赛海外大卖,国内却遇冷。国内CAR-T市场低迷、高价难入医保,企业如何破局?近期,一则有关传奇生物裁撤中国销售团队的消息在行业内悄然流传。传奇生物作为国产CAR-T细胞疗法出海的佼佼者,凭借其针对BCMA靶点的CAR-T产品Carvykti(西达基奥...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10